DE602005019919D1 - Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe - Google Patents

Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe

Info

Publication number
DE602005019919D1
DE602005019919D1 DE602005019919T DE602005019919T DE602005019919D1 DE 602005019919 D1 DE602005019919 D1 DE 602005019919D1 DE 602005019919 T DE602005019919 T DE 602005019919T DE 602005019919 T DE602005019919 T DE 602005019919T DE 602005019919 D1 DE602005019919 D1 DE 602005019919D1
Authority
DE
Germany
Prior art keywords
fascinating
orange
active substances
soluble active
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005019919T
Other languages
English (en)
Inventor
Sukhjeet Singh
Rajesh Jain
Rohit Kumar
Winter Marius L De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Abbott Healthcare Products BV
Original Assignee
Panacea Biotec Ltd
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd, Solvay Pharmaceuticals BV filed Critical Panacea Biotec Ltd
Priority claimed from PCT/EP2005/056970 external-priority patent/WO2006067150A1/en
Publication of DE602005019919D1 publication Critical patent/DE602005019919D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005019919T 2004-12-23 2005-12-20 Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe Active DE602005019919D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63811104P 2004-12-23 2004-12-23
EP04106933 2004-12-23
PCT/EP2005/056970 WO2006067150A1 (en) 2004-12-23 2005-12-20 Oral immediate release formulation of a poorly watersoluble active substance

Publications (1)

Publication Number Publication Date
DE602005019919D1 true DE602005019919D1 (de) 2010-04-22

Family

ID=35890662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005019919T Active DE602005019919D1 (de) 2004-12-23 2005-12-20 Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe

Country Status (4)

Country Link
KR (1) KR20070104890A (de)
DE (1) DE602005019919D1 (de)
IL (1) IL183554A (de)
NO (1) NO20073728L (de)

Also Published As

Publication number Publication date
NO20073728L (no) 2007-07-18
IL183554A0 (en) 2007-09-20
KR20070104890A (ko) 2007-10-29
IL183554A (en) 2011-07-31

Similar Documents

Publication Publication Date Title
ATE337793T1 (de) Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
EP1951211A4 (de) Transdermale zubereitungen mit hydrophoben nicht-steroidalen entzündungshemmern
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
IL216734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
IL221770A (en) Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug
ATE507246T1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
IL194184A0 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
ATE439832T1 (de) Feste pharmazeutische arzneimittelformulierung enthaltend diacerein und meloxicam
MA29076B1 (fr) Préparations pharmaceutiques comprenant un dérivé de camptothécine
FR2901273B1 (fr) Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
NO20055601D0 (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
FR2888748B1 (fr) Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
ATE460167T1 (de) Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DE602004014624D1 (de) Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
IL172096A0 (en) Pharmaceutical formulations comprising amoxicillin and clavulanate
DE602005019919D1 (de) Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe
HK1086819A1 (en) 2-(butyl-1-sulfonylamino)-n-(1(r)-(6-methoxy-pyridin-3-yl)-propyl)-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
ECSP067030A (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
AU2002328000A1 (en) Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
ATE373488T1 (de) Antimykobakterielle pharmazeutische zusammensetzung mit einem arzneimittel gegen tuberkulose

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PANACEA BIOTEC LTD., NEW DELHI, IN

Owner name: ABBOTT HEALTHCARE PRODUCTS B.V., WEESP, NL

8364 No opposition during term of opposition